X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8954) 8954
Book Chapter (24) 24
Dissertation (10) 10
Publication (4) 4
Magazine Article (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
blood-stream infections (6303) 6303
humans (6298) 6298
infectious diseases (3276) 3276
female (2760) 2760
male (2753) 2753
microbiology (2577) 2577
middle aged (2003) 2003
mortality (1938) 1938
epidemiology (1870) 1870
aged (1761) 1761
risk factors (1753) 1753
risk-factors (1739) 1739
adult (1692) 1692
blood-stream infection (1588) 1588
bacteremia (1482) 1482
health aspects (1184) 1184
retrospective studies (1135) 1135
anti-bacterial agents - therapeutic use (1126) 1126
infections (1070) 1070
pharmacology & pharmacy (1047) 1047
nosocomial infections (1038) 1038
prevention (995) 995
intensive-care-unit (908) 908
aged, 80 and over (896) 896
hospitals (891) 891
microbial sensitivity tests (875) 875
cross infection - epidemiology (868) 868
immunology (867) 867
surveillance (845) 845
sepsis (836) 836
adolescent (834) 834
child (800) 800
bacteremia - microbiology (780) 780
research (780) 780
intensive care units (762) 762
antibiotics (756) 756
pediatrics (749) 749
cross infection - microbiology (734) 734
treatment outcome (734) 734
incidence (718) 718
animals (704) 704
prospective studies (701) 701
anti-bacterial agents - pharmacology (696) 696
analysis (686) 686
public, environmental & occupational health (686) 686
critically-ill patients (675) 675
infectious disease (670) 670
infant, newborn (649) 649
critical care medicine (637) 637
central venous catheters (633) 633
cross infection - prevention & control (632) 632
medicine, general & internal (628) 628
infant (616) 616
impact (605) 605
child, preschool (601) 601
management (593) 593
infection (584) 584
young adult (574) 574
catheterization, central venous - adverse effects (572) 572
resistance (571) 571
bacteremia - epidemiology (569) 569
infection control (541) 541
diagnosis (539) 539
cross infection (535) 535
care and treatment (534) 534
ventilator-associated pneumonia (525) 525
bacteremia - drug therapy (513) 513
prevalence (513) 513
drug resistance (509) 509
outcomes (507) 507
catheters (506) 506
escherichia-coli (500) 500
colonization (483) 483
therapy (483) 483
antifungal agents - therapeutic use (467) 467
bacteria (463) 463
antimicrobial resistance (462) 462
drug resistance in microorganisms (460) 460
children (458) 458
staphylococcus aureus (455) 455
risk (445) 445
united-states (443) 443
candidemia (442) 442
complications (439) 439
abridged index medicus (436) 436
pneumonia (431) 431
patients (421) 421
catheter-related infections - prevention & control (412) 412
candida - isolation & purification (404) 404
surgery (401) 401
candidiasis - microbiology (399) 399
bacteremia - mortality (395) 395
research article (395) 395
klebsiella-pneumoniae (394) 394
internal medicine (392) 392
cohort studies (390) 390
drug resistance, bacterial (390) 390
susceptibility (388) 388
antifungal agents - pharmacology (387) 387
pathogens (383) 383
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8584) 8584
Spanish (184) 184
German (92) 92
French (77) 77
Japanese (38) 38
Turkish (20) 20
Portuguese (12) 12
Russian (6) 6
Czech (5) 5
Polish (4) 4
Chinese (3) 3
Hungarian (2) 2
Korean (2) 2
Italian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Burns, ISSN 0305-4179, 2017, Volume 43, Issue 3, pp. 642 - 653
Highlights • Burn depth/agent increases risk of developing an infection. • Infections found folliculitis, burn wound, urinary tract, pneumonia, CVC and bloodstream... 
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | URINARY-TRACT-INFECTION | MORTALITY | SURGERY | RISK-FACTORS | DERMATOLOGY | REPLACEMENT | BACTERIOLOGY | CATHETERS | INTENSIVE-CARE-UNIT | SURVEILLANCE | ASSOCIATION | BLOOD-STREAM INFECTIONS | CRITICAL CARE MEDICINE | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents
Journal Article
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial stewardship oversight significantly... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Objective. We compared differences in the hospital charges, length of hospital stay, and mortality between patients with healthcare- and community-associated bloodstream infections, urinary tract infections... 
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | MORTALITY | INFECTIOUS DISEASES | ESCHERICHIA-COLI | EUROPEAN HOSPITALS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | IMMUNOLOGY | METHICILLIN-RESISTANCE | ENTEROCOCCUS | BACTEREMIA | STAPHYLOCOCCUS-AUREUS | BURDEN | BLOOD-STREAM INFECTIONS | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | and Commentaries
Journal Article
Infection control and hospital epidemiology, ISSN 1559-6834, 2015, Volume 32, Issue 2, pp. 101 - 114
Objective. To estimate the proportion of healthcare-associated infections (HAIs) in US hospitals... 
Labor costs | Health care costs | Intensive care units | Hospital costs | Cost estimates | Original Article | Average total cost | Infections | Economic costs | Cost analysis | Cost control | URINARY-TRACT-INFECTION | INFECTIOUS DISEASES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | UNIT PATIENTS | VENTILATOR-ASSOCIATED PNEUMONIA | SURGICAL-SITE INFECTIONS | EDUCATION-PROGRAM | HOSPITALS | MEDICAL-CENTER | BLOOD-STREAM INFECTIONS | NOSOCOMIAL INFECTIONS | ATTRIBUTABLE MORTALITY | United States - epidemiology | Sepsis - etiology | Sepsis - prevention & control | Cross Infection - economics | Humans | Cross Infection - mortality | Equipment Contamination - economics | Urinary Tract Infections - economics | Urinary Tract Infections - prevention & control | Infection Control - methods | Pneumonia, Ventilator-Associated - economics | Pneumonia, Ventilator-Associated - epidemiology | Catheter-Related Infections - prevention & control | Catheters - adverse effects | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Equipment Contamination - prevention & control | Sepsis - economics | Surgical Wound Infection - epidemiology | Catheter-Related Infections - economics | Costs and Cost Analysis | Risk Assessment | Cross Infection - prevention & control | Surgical Wound Infection - economics | Pneumonia, Ventilator-Associated - prevention & control | Surgical Wound Infection - etiology | Surgical Wound Infection - prevention & control | Regression Analysis | Urinary Tract Infections - epidemiology | Catheters - microbiology | Urinary Tract Infections - etiology | Health Care Surveys
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2012, Volume 40, Issue 5, pp. 396 - 407
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC... 
Infectious Disease | Infection Control | Nosocomial infection | Ventilator-associated pneumonia | Low-income countries | Bloodstream infection | Developing countries | Central line-associated bloodstream infection | Limited-resources countries | Health care-associated infection | Urinary tract infection | Catheter-associated urinary tract infection | Network | Antibiotic resistance | Hospital infection | Device-associated infection | MORTALITY | INTENSIVE-CARE UNITS | CONTROL PROGRAM | RATES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PERFORMANCE FEEDBACK | SAFETY NETWORK | INFECTIOUS DISEASES | LENGTH-OF-STAY | ARGENTINEAN HOSPITALS | BLOOD-STREAM INFECTIONS | Africa - epidemiology | Prevalence | Prospective Studies | Humans | Middle Aged | Cross Infection - mortality | Child, Preschool | Infant | Male | Young Adult | Aged, 80 and over | Bacteria - classification | Adult | Female | Child | Infant, Newborn | Cross Infection - epidemiology | Latin America - epidemiology | Intensive Care Units | Europe - epidemiology | International Cooperation | Asia - epidemiology | Bacteria - isolation & purification | Adolescent | Bacterial Infections - epidemiology | Aged | Bacterial Infections - mortality | Consortia | Medical colleges | Pneumonia | Hotels and motels | Bacterial pneumonia | Staphylococcus aureus infections | Urinary tract infections | Health aspects | Antibacterial agents | Public health | Infection control
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 2015, Volume 21, Issue 1, pp. S1 - S25
Biofilms cause chronic infections in tissues or by developing on the surfaces of medical devices... 
biofilm infections | biofilm-based infections | biofilm | biofilm treatment | guidelines | biofilm-associated infections | biofilm diagnosis | Biofilm infections | Biofilm-associated infections | Biofilm treatment | Biofilm-based infections | Biofilm | Biofilm diagnosis | Guidelines | URINARY-TRACT-INFECTION | INFECTIOUS DISEASES | BLOOD-STREAM INFECTION | associated infections | VENTILATOR-ASSOCIATED PNEUMONIA | PROSTHETIC JOINT INFECTION | IN-SITU HYBRIDIZATION | MICROBIOLOGY | RANDOMIZED CONTROLLED-TRIAL | based infections | CLINICAL-PRACTICE GUIDELINES | CATHETER-RELATED BACTEREMIA | CENTRAL VENOUS CATHETERS | ENDOTRACHEAL-TUBE BIOFILM | Biofilms - drug effects | Wound Infection - diagnosis | Surgical Procedures, Operative | Humans | Biofilms - growth & development | Pneumonia, Bacterial - diagnosis | Catheter-Related Infections - therapy | Prosthesis-Related Infections - therapy | Anti-Bacterial Agents - therapeutic use | Pneumonia, Bacterial - drug therapy | Catheter-Related Infections - diagnosis | Prosthesis-Related Infections - diagnosis | Wound Infection - therapy | Wound Infection/diagnosis | Prosthesis-Related Infections/diagnosis | Biofilms/drug effects | Pneumonia, Bacterial/diagnosis | Catheter-Related Infections/diagnosis | Biofilms/growth & development | Catheter-Related Infections/therapy | Life Sciences | Microbiology and Parasitology | Pneumonia, Bacterial/drug therapy | Prosthesis-Related Infections/therapy | Wound Infection/therapy | Anti-Bacterial Agents/therapeutic use
Journal Article
Journal of Infection, ISSN 0163-4453, 2012, Volume 64, Issue 5, pp. 478 - 483
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1744-7666, 2014, Volume 16, Issue 2, pp. 159 - 177
Journal Article